New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 21, 2013
10:15 EDTAGU, CRH, SNY, AEO, VELT, DKS, TUP, POT, MOS, HMY, CHK, GHLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Agrium (AGU) downgraded to Neutral from Overweight at HSBC... Chesapeake (CHK) downgraded to Neutral from Positive at Susquehanna... Harmony Gold (HMY) downgraded to Sell from Neutral at UBS... Mosaic (MOS) downgraded to Underweight from Neutral at HSBC... Potash (POT) downgraded to Underweight from Overweight at HSBC... Tupperware Brands (TUP) downgraded to Market Perform from Outperform at BMO Capital... Dick's Sporting (DKS) downgraded to In-Line from Outperform at Imperial Capital... Velti (VELT) downgraded at RBC Capital... American Eagle (AEO) downgraded to Neutral from Overweight at Piper Jaffray... Sanofi (SNY) downgraded to Market Perform from Outperform at Cowen... CRH Plc. (CRH) downgraded to Outperform from Strong Buy at Raymond James... Greenhill & Co. (GHL) downgraded to Market Perform from Outperform at JMP Securities.
News For AGU;CHK;HMY;MOS;POT;TUP;DKS;VELT;AEO;SNY;CRH;GHL From The Last 14 Days
Check below for free stories on AGU;CHK;HMY;MOS;POT;TUP;DKS;VELT;AEO;SNY;CRH;GHL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
August 12, 2014
10:00 EDTAEOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:52 EDTSNYSanofi launches authorized generic version of Eloxatin through Winthrop US
Subscribe for More Information
08:42 EDTAEOAmerican Eagle initiated with a Hold at Wunderlich
Target $11.
08:03 EDTDKSGoldman's Retail selections for Q2
Goldman is most above Q2 consensus for Advance Auto Parts (AAP), Best Buy (BBY) and Williams-Sonoma (WSM), sees best risk/reward in Ulta Salon (ULTA) and Sportsman's Warehouse (SPWH), and low visibility in Dick's Sporting (DKS) and Wal-Mart (WMT).
August 11, 2014
15:51 EDTSNYMannKind price target raised to $10 from $6.50 at Piper Jaffray
Subscribe for More Information
11:58 EDTSNYMannKind rallies after inking licensing agreement with Sanofi
Subscribe for More Information
09:06 EDTSNYOn The Fly: Pre-market Movers
HIGHER: PharmAthene (PIP), up 55% after announcing that a Delaware court awarded the company lump sum expectation damages for the value of its lost profits for SIGA Technologies' (SIGA) smallpox antiviral, Tecovirimat... MannKind (MNKD), up 19% after entering exclusive licensing agreement for development and commercialization of Afrezza inhaled insulin with Sanofi (SNY)... Kinder Morgan (KMI), up 19% after announcing it will acquire all of the outstanding equity securities of Kinder Morgan Energy Partners (KMP), Kinder Morgan Management (KMR) and El Paso Pipeline Partners (EPB)... Tesla (TSLA), up 2.7% following upgrade at Deutsche Bank... Achillion (ACHN), up 6% following upgrades at Wells Fargo and at Piper Jaffray... PepsiCo (PEP), up 0.9% following upgrade at UBS. LOWER: Dean Foods (DF), down 8.6% after reporting Q2 losses that were steeper than expected, saying balance of year "appears rocky," which makes it difficult to provide guidance beyond the immediate quarter... Priceline (PCLN), down 0.7% after reporting Q2 revenue that missed expectations, guiding Q3 EPS below consensus... SIGA Technologies, down 31% after ruling in suit with PharmAthene... 2U (TWOU), down 4.3% after downgraded at Goldman.
07:45 EDTSNYMannKind partnership likely to be viewed favorably, says Piper Jaffray
Subscribe for More Information
07:07 EDTSNYIgnyta names Adrian Senderowicz as Chief Medical Officer
Ignyta (RXDX) announced that Adrian Senderowicz, M.D., has been appointed as Chief Medical Officer and SVP, Clinical Development and Regulatory Affairs. Senderowicz was most recently Vice President, Global Regulatory Oncology at Sanofi (SNY).
06:52 EDTDKSDick's Sporting still has a downward bias to estimates, says RBC Capital
Subscribe for More Information
06:31 EDTSNYMannKind to host conference call
Conference call to discuss the collaboration with Sanofi about global licensing agreement for development and commercialization of Afrezza will be held on August 11 at 8:30 am. Webcast Link
05:13 EDTSNYSanofi, MannKind announce global licensing agreement for Afrezza
Subscribe for More Information
August 8, 2014
12:12 EDTDKSDick's Sporting volatility elevated into Q2 and outlook
Subscribe for More Information
10:36 EDTDKSOptions with increasing implied volatility
Subscribe for More Information
10:16 EDTDKSHigh option volume stocks
High option volume stocks: TKMR JOE HMSY TDC XOMA XPO VGK DKS BCOR DRTX
August 7, 2014
10:00 EDTCHKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:40 EDTSNYSanofi and Immune Design enters licensing agreement for use of GLASStm
Subscribe for More Information
07:48 EDTCHKChesapeake upgraded at Stifel
As noted earlier, Stifel upgraded Chesapeake to Buy from Hold. The firm believes that the company's Q2 results confirm that the company is becoming well-positioned from a capex efficiency perspective heading into 2015. The firm expects the company's 2015 production to come in at the high end of guidance, and it thinks the stock has reached a good entry point. Target $34.
07:42 EDTSNYPOZEN plans to make future employee reductions
Subscribe for More Information
06:22 EDTCHKChesapeake upgraded to Buy from Hold at Stifel
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use